What is the FATE stock price prediction for next 2 weeks?

According to our price prediction algorithm,Fate Therapeutics, Inc. (FATE) price will be around $2.21 in the next 2 weeks. This means it will increase by 26.12535612535612 from the last closing price. This prediction may vary from other time period filters for FATE stock.

What can be the highest Possible price of FATE stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, FATE can achieve the highest price of $2.52 which is 43.547560236374935 higher than last closing price. This prediction may vary from other time period filters for FATE stock.

What can be the lowest Possible price of FATE stock in next 2 weeks?

As per the forecast and algorithmic analysis, FATE stock price can be as low as $1.90 which is 8.060429337271682 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for FATE stock.

Will FATE stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that FATE stock will gain26.12535612535612 in the next 2 weeks. This prediction may vary from other time period filters for FATE stock.

What is FATE stock last closing price?

Last closing price of FATE stock was $1.76.

What is FATE stock price prediction?

FATE stock price prediction means predicting the future closing prices of FATE stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of FATE stock in a certain time period.

How we predict FATE stock future prices?

If you are searching for FATE stock forecast, analysis or price prediction, then you might be wondering what Fate Therapeutics, Inc. (FATE) will do in the future. Our FATE price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This FATE price prediction will likely answer most of your questions.

How frequent we update FATE stock predictions?

We are updating the forecasts for the FATE stock on daily basis.

Is using ML forecasting for FATE stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for FATE stock same for all the time periods?

No, the prediction for FATE stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Fate Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.7640.8%Since 2 Weeks

Predicted Price$2.2126.13%For 2 Weeks

Upper Predicted Price$2.5243.55%For 2 Weeks

Lower Predicted Price$1.908.06%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of FATE will rise by +26.13% over the next 2 Weeks and hit $2.21 by Friday, May 29, 2026. In that time frame, FATE's share price is expected to range between $1.90 and $2.52.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 29, 2026	1.90	2.21	2.52
May 28, 2026	1.77	2.08	2.41
May 27, 2026	1.79	2.10	2.42
May 26, 2026	1.79	2.09	2.41
May 25, 2026	1.70	2.02	2.35
May 22, 2026	1.74	2.06	2.36
May 21, 2026	1.58	1.93	2.24
May 20, 2026	1.60	1.94	2.27
May 19, 2026	1.61	1.94	2.27
May 18, 2026	1.55	1.86	2.17

FATE shares fell -7.63% in Friday, May 15, 2026's trading session, dropping from a previous close of $1.90 to move at $1.76. The stock demonstrated notable intraday movement (see FATE's key stats for a full breakdown), fluctuating between $1.71 and $1.91, a +11.70% trading range. While recent weeks have seen some volatility, FATE has managed to secure a -2.50% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 2.06M shares changing hands, 1.7M fewer than the previous session. This amounted to $3.61M in total market activity.

Will FATE Continue Its Upward Trend?

According to analyst ratings and projections for FATE, Fate Therapeutics, Inc. shares are anticipated to increase by +30.34%, potentially reaching $2.52 per share by May 29, 2026. Short-term technical indicators currently suggest a bullish sentiment for FATE. However, the stock has recorded 16 negative trading days within the past 30 sessions. Based on the FATE stock forecast, now is a good time to buy FATE stock because its current trading price is -20.71% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on FATE covering social and institutional perspectives.

FATE Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into FATE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.90% to 53.36%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 54.86%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.93%, maintains a neutral outlook for the long term. Insights into FATE's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Fate Therapeutics Short-Term Forecasts

FATE Forecast For Next 5 Days

Our algorithm anticipates Fate Therapeutics (FATE) stock could hit $1.77 by May 22, 2026. This represents a +1.03% rise from today's price, following a +2.80% change over the past five days.

FATE Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Fate Therapeutics, Inc. (FATE) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $2.08, which would mean a +18.52% increase from the current price of $1.76. Projections for this period range from a high of $2.91 to a low of $1.34.

FATE Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Fate Therapeutics's price over the next three months point to a rise. FATE stock is expected to peak at $9.02 on Aug 03, 2026 after potentially dipping to $5.92 on May 22, 2026. On average, FATE is likely to trade around $7.39 in the coming 90 days.

Fate Therapeutics Stock Forecast 2025

Based on our predictive models, Fate Therapeutics (FATE) is expected to trade between $1.34 and $9.02 throughout 2026. This would result in an average price of $7.67, potentially offering investors a +337.04% return from current levels.

Fate Therapeutics, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Fate Therapeutics, Inc. (FATE) is positioned to show a strong performance in May 2026. The price is predicted to move between $5.92 and $6.27, settling at an average of $6.09. This could translate to a +247.01% gain.

June 2026

Based on current market signals, Fate Therapeutics, Inc. is projected to trend june 2026. We forecast a trading range from $6.21 to $7.38, with a likely average price of $6.92. Investors could expect a potential return of +294.30%.

July 2026

Our predictive algorithms indicate Fate Therapeutics, Inc. stock may see a shift in July 2026. The expected range spans $6.51–$9.00, with an average target of $7.88. This represents a positive outlook and a possible gain of +349.00%.

August 2026

Analyzing established trends, Fate Therapeutics, Inc. looks set to move in August 2026. Projections place the stock between $6.69 and $9.02, averaging around $8.26. This suggests a +370.66% gain from current levels.

September 2026

Market indicators suggest Fate Therapeutics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $5.60 to $8.37, with a midpoint forecast of $8.33. The stock might deliver a +374.64% gain.

October 2026

Forecasting for October 2026, models estimate that Fate Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.94 and $8.03, averaging $7.78. This signals a positive trajectory with potential returns around +343.30%.

November 2026

According to our latest forecast models, Fate Therapeutics, Inc. (FATE) is positioned to show a strong performance in November 2026. The price is predicted to move between $2.65 and $7.48, settling at an average of $7.64. This could translate to a +335.33% gain.

December 2026

Based on current market signals, Fate Therapeutics, Inc. is projected to trend december 2026. We forecast a trading range from $1.34 to $8.14, with a likely average price of $7.63. Investors could expect a potential return of +334.76%.

January 2027

Our predictive algorithms indicate Fate Therapeutics, Inc. stock may see a shift in January 2027. The expected range spans $0.04–$9.54, with an average target of $8.97. This represents a positive outlook and a possible gain of +411.11%.

February 2027

Analyzing established trends, Fate Therapeutics, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $10.12, averaging around $9.29. This suggests a +429.34% gain from current levels.

March 2027

Market indicators suggest Fate Therapeutics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $11.17, with a midpoint forecast of $9.32. The stock might deliver a +431.05% gain.

April 2027

Forecasting for April 2027, models estimate that Fate Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $11.55, averaging $8.93. This signals a positive trajectory with potential returns around +408.83%.

May 2027

According to our latest forecast models, Fate Therapeutics, Inc. (FATE) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $12.31, settling at an average of $8.33. This could translate to a +374.64% gain.

FATE's history of dividends and stock splits also plays a role in long-term investor confidence.